Role of mTOR signaling in tumor cell motility, invasion and metastasis

• Published in: Current protein & peptide science Vol. 12; no. 1; p. 30
• Main Authors: Zhou, Hongyu, Huang, Shile
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01-02-2011
• Subjects: Cell Movement; Humans; Neoplasm Invasiveness - physiopathology; Neoplasm Metastasis - physiopathology; Signal Transduction; TOR Serine-Threonine Kinases - metabolism
• ISSN: 1875-5550
• DOI: 10.2174/138920311795659407

Tumor cell migration and invasion play fundamental roles in cancer metastasis. The mammalian target of rapamycin (mTOR), a highly conserved and ubiquitously expressed serine/threonine (Ser/Thr) kinase, is a central regulator of cell growth, proliferation, differentiation and survival. Recent studies have shown that mTOR also plays a critical role in the regulation of tumor cell motility, invasion and cancer metastasis. Current knowledge indicates that mTOR functions as two distinct complexes, mTORC1 and mTORC2. mTORC1 phosphorylates p70 S6 kinase (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1), and regulates cell growth, proliferation, survival and motility. mTORC2 phosphorylates Akt, protein kinase C α (PKCα) and the focal adhesion proteins, and controls the activities of the small GTPases (RhoA, Cdc42 and Rac1), and regulates cell survival and the actin cytoskeleton. Here we briefly review recent knowledge of mTOR complexes and the role of mTOR signaling in tumor cell migration and invasion. We also discuss recent efforts about the mechanism by which rapamycin, a specific inhibitor of mTOR, inhibits cell migration, invasion and cancer metastasis.